Artificial intelligence already plays a role in prior authorization across many health plans. How does it change performance in measurable ways? And where does it introduce new forms of risk that require active management?
For organizations with mature utilization management programs, AI is less a transformation story and more a pressure test. It exposes gaps in policy design, data quality, and operational discipline. It also creates opportunities to refine how prior authorization functions as a clinical and administrative control.
Shortened decision timelines and public reporting requirements have increased pressure on authorization performance. In that context, AI is often evaluated less as an innovation initiative and more as a mechanism for meeting turnaround expectations at scale.1
This pressure has also increased alongside CMS interoperability and burden reduction initiatives, which continue to push health plans toward faster, more transparent authorization workflows.
Let’s look at where improvement is emerging, where results are mixed, and where risks are starting to surface in ways that require closer attention.
Where AI Moves the Needle
Gains from AI in prior authorization can fall into three categories: speed, consistency, and workload distribution. But these improvements may concentrate in specific parts of the workflow rather than across the entire process.
Turnaround time may improve first. Automated intake, documentation review, and policy matching reduce queue time for straightforward cases. Plans that relied on manual triage can process a higher percentage of requests within standard timeframes.
Even back in 2022, a survey found that 3 in 4 health insurance providers used electronic prior authorization to streamline prescription medication requests, and nearly 90% used electronic prior authorization to streamline medical services.2 CMS has also shared that electronic prior authorization (ePA) can reduce processing timelines and save hundreds of hours a year for providers that they can now spend caring for patients.3
Decision consistency improves when clinical criteria are translated into structured logic. Variability tied to reviewer interpretation decreases for cases that align clearly with policy guidelines. This becomes especially important as organizations track denial patterns and prepare for external reporting.
Workload redistribution may be the most operationally significant effect. As automation absorbs routine tasks, clinical staff spend more time on complex reviews, appeals, and provider discussions. This changes how teams allocate expertise rather than simply reducing effort.
The American Medical Association estimates that physician practice staff complete an average of 45 prior authorizations per physician per week, illustrating the administrative intensity surrounding these processes.4 Early survey findings on AI adoption in healthcare workflows also show measurable operational gains, with 57% of respondents reporting that AI somewhat or substantially improved efficiency and productivity within their organizations.5 These improvements can help organizations redirect staff effort toward higher-acuity reviews and provider engagement.
These gains can plateau if underlying issues remain unresolved. AI can accelerate a process, but it doesn’t correct unclear policy criteria, fragmented data, or inconsistent escalation practices.
Evidence Depends on What You Measure
One challenge in evaluating AI’s impact on prior authorization is that results depend heavily on which metrics an organization prioritizes.
If the focus is processing speed, AI performs well. If the focus shifts to clinical appropriateness or downstream utilization, the picture becomes more complex.
Faster approvals may improve provider satisfaction and reduce administrative burden. They may also improve member satisfaction when determinations occur almost immediately rather than over multiple days. For many organizations, reduced concern around regulatory turnaround requirements has become another operational benefit tied to automation adoption. At the same time, if approval logic is too permissive or lacks sufficient clinical nuance, utilization patterns may affect cost trends.
Reductions in denial rates could appear positive at first glance. But without context, they don’t indicate whether decisions are more clinically appropriate or simply less restrictive.
Teams are evaluating AI performance across a broader set of indicators:
- Alignment between authorization decisions and clinical outcomes
- Appeal rates and overturn frequency
- Variation in decisions across similar case types
- Impact on downstream cost and utilization
- Provider response patterns following authorization decisions
This view often reveals that AI improves operational metrics faster than it improves clinical alignment. Closing that gap requires ongoing refinement rather than one-time implementation.
Data Quality Is Still the Constraint
AI performance in prior authorization depends on the quality and structure of incoming data. This is still one of the most limiting factors.
Even with increased adoption of electronic prior authorization and interoperability standards, many requests include unstructured notes, incomplete documentation, or inconsistent coding. AI tools can process these inputs to a degree, but accuracy declines when data lacks standardization.
This creates a ceiling. Automation works well for cases with clean, structured data and clear policy alignment. It struggles when documentation is ambiguous or when clinical context extends beyond discrete data fields.
Some organizations will respond by tightening submission requirements or expanding structured data capture through provider portals and APIs. Others will invest in tools that extract meaning from unstructured inputs. Both approaches help, but neither fully eliminates the issue.
Policy Design Becomes More Visible
AI forces a level of precision in clinical policy that manual processes can sometimes obscure.
When policies are translated into decision logic, gaps and ambiguities become harder to ignore. Criteria that rely on subjective interpretation or lack clear thresholds can produce inconsistent outputs when automated.
This leads some organizations to revisit how policies are written and maintained. Instead of relying on narrative guidelines alone, they can develop more structured criteria that can be applied consistently across both automated and manual reviews. This improves auditability, supports clearer denial rationale, and reduces variation across reviewers.
As organizations adapt to CMS interoperability requirements and state-level burden reduction initiatives, clearer policy logic and standardized workflows are more important for maintaining regulatory compliance and supporting defensible authorization decisions.
Emerging Risk Signals
As AI adoption expands, several risk patterns are becoming more apparent.
- Over-reliance on automated pathways can lead to edge cases receiving insufficient review
- Drift between policy and practice can happen when automated logic is not updated alongside evolving clinical guidance
- Opaque decision logic creates challenges in explaining outcomes to providers and regulators
- Concentration of errors increases when flawed logic scales across large volumes
- Provider behavior changes may follow predictable approval or denial patterns, influencing utilization trends over time
Industry discussions around AI governance in healthcare have also raised concerns about model drift, oversight accountability, and the need for stronger governance frameworks as automated decision-making becomes more embedded in clinical and administrative workflows.
Clinical oversight is becoming more targeted. Instead of reviewing every case, clinicians are focusing on complex scenarios, appeals, policy refinement, and provider discussions. This makes escalation design more important than ever.
AI is reshaping how prior authorization operates across utilization management.
Some organizations are also confronting a practical constraint: scaling prior authorization purely through staffing is not sustainable. As documentation requirements expand and turnaround expectations tighten, adding clinical reviewers alone does not keep pace with demand. This dynamic is one reason AI has gained traction as a support layer within prior authorization workflows.1
Workflows become more segmented. Data flows become more central. Clinical roles shift toward higher-complexity activities. Governance structures take on greater importance.
This has implications for how organizations structure their teams and systems. Prior authorization increasingly intersects with IT, data governance, compliance, and provider engagement.
A More Grounded View of AI’s Role
AI does improve prior authorization, but not in a uniform or automatic way. The most meaningful improvements tend to occur when:
- Clinical policies are clearly defined and structured
- Data inputs are consistent and accessible
- Workflows support segmentation and escalation
- Governance processes monitor performance and adjust logic
- Clinical teams remain actively involved in oversight
Without these elements, automation may accelerate existing problems rather than resolve them. AI is not a replacement for clinical judgment in prior authorization. It changes how judgment is applied and where it is most needed.
Growth in the industry so far shows operational gains, mixed clinical impact depending on implementation, and emerging risks that require active management.
For managed care organizations, the focus is on controlling how AI shapes authorization performance over time.
Clearlink works with health plans to strengthen prior authorization across both clinical and operational management functions. By aligning technology with policy, data, and governance, organizations can build more consistent, efficient, and accountable authorization programs.
Contact our team to discuss your team’s automation success and see how we can help streamline authorization processes.
Sources:
1. AI Could Help Health Plans Simplify Prior Auth, Comply with Regs
2. AHIP 2022 Survey on Prior Authorization Practices & Gold Carding Experiences, AHIP
3. Moving Prior Authorization into the 21st Century, CMS
4. Toll from Prior Authorization Exceeds Alleged Benefits, Say Physicians, AMA
5. AI Adoption in Healthcare Report 2024, HIMSS